NG GEORGE K (Chief Executive Officer) purchased 27.2% of their position (2.13K shares) of PROCESSA PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $5.5K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/1/2026ACC: 0000897069-26-001291
Officer· Chief Executive Officer
Since Aug 2023
+2.13K
Net shares
Net buyer
$5.5K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
2.13K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2.13K
Price / share
$2.57
Trade value
$5.47K
% of position
27.2%
5/29/2026
7.84K→9.97K
Total
Net shares
+2.13K
Net value
$5.47K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/29/2026 | P · Purchase | +2.13K | $2.57 | $5.47K | 27.2% | 7.84K | 9.97K |
| Total | +2.13K | $5.47K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned800.00
Common Stock
IndirectShares owned3.49K
Total
4.29K indirect4.29K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 800.00 | Indirect |
| Common Stock | 3.49K | Indirect |
| Total | 4.29K | 4.29K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported